Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The miR-29 family in hematological malignancies

B. Fiserova, L. Kubiczkova, L. Sedlarikova, R. Hajek, S. Sevcikova

. 2015 ; 159 (2) : 184-191. [pub] 20140704

Language English Country Czech Republic

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

Grant support
NT12130 MZ0 CEP Register
NT14575 MZ0 CEP Register

BACKGROUND: MicroRNAs are short non-coding regulators of gene expression. The human miR-29 family consists of three members: miR-29a, miR-29b and miR-29c. Members of this family were found to be aberrantly expressed in various types of tumors, including hematological malignancies. This family was described to have both oncogenic and tumor suppressor features influencing various pathological processes, such as tumor growth and apoptosis. This review summarizes current knowledge about the miR-29 family in selected hematological malignancies. CONCLUSION: Recent research of miR-29 family in hematological malignancies has proven its oncogenic as well as tumor suppressive potential. Nevertheless, the level of current evidence is not sufficient, and data remain inconclusive.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17006074
003      
CZ-PrNML
005      
20200219094214.0
007      
ta
008      
170210s2015 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2014.037 $2 doi
035    __
$a (PubMed)25004911
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Fišerová, Barbora $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
245    14
$a The miR-29 family in hematological malignancies / $c B. Fiserova, L. Kubiczkova, L. Sedlarikova, R. Hajek, S. Sevcikova
520    9_
$a BACKGROUND: MicroRNAs are short non-coding regulators of gene expression. The human miR-29 family consists of three members: miR-29a, miR-29b and miR-29c. Members of this family were found to be aberrantly expressed in various types of tumors, including hematological malignancies. This family was described to have both oncogenic and tumor suppressor features influencing various pathological processes, such as tumor growth and apoptosis. This review summarizes current knowledge about the miR-29 family in selected hematological malignancies. CONCLUSION: Recent research of miR-29 family in hematological malignancies has proven its oncogenic as well as tumor suppressive potential. Nevertheless, the level of current evidence is not sufficient, and data remain inconclusive.
650    _2
$a apoptóza $x genetika $7 D017209
650    _2
$a stárnutí buněk $x genetika $7 D016922
650    _2
$a proliferace buněk $x genetika $7 D049109
650    _2
$a nádorová transformace buněk $x genetika $7 D002471
650    _2
$a extracelulární matrix $x genetika $7 D005109
650    _2
$a tumor supresorové geny $x fyziologie $7 D016147
650    _2
$a hematologické nádory $x genetika $7 D019337
650    _2
$a lidé $7 D006801
650    _2
$a mikro RNA $x genetika $x fyziologie $7 D035683
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Bešše, Lenka $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno $7 mub2014851432
700    1_
$a Sedlaříková, Lenka $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno $7 xx0214571
700    1_
$a Hájek, Roman, $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno $d 1964- $7 nlk20000083645
700    1_
$a Ševčíková, Sabina, $d 1972- $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno $7 mub2015859787
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 159, č. 2 (2015), s. 184-191
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20170210 $b ABA008
991    __
$a 20200219094616 $b ABA008
999    __
$a ok $b bmc $g 1192599 $s 966721
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 159 $c 2 $d 184-191 $e 20140704 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
GRA    __
$a NT12130 $p MZ0
GRA    __
$a NT14575 $p MZ0
LZP    __
$b NLK118 $a Pubmed-20170210

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...